UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 42

Sortiert nach

Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses

Journal of clinical oncology, 2011-10, Vol.29 (28), p.3768-3774

2011

Volltextzugriff (PDF)

Phase III Trial of Irinotecan/Cisplatin Compared With Etoposide/Cisplatin in Extensive-Stage Small-Cell Lung Cancer: Clinical and Pharmacogenomic Results From SWOG S0124

Journal of clinical oncology, 2009-05, Vol.27 (15), p.2530-2535

2009

Volltextzugriff (PDF)

Effects of exercise on inflammation in patients receiving chemotherapy: a nationwide NCORP randomized clinical trial

Supportive care in cancer, 2019-12, Vol.27 (12), p.4615-4625

2019

Volltextzugriff (PDF)

Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: Results From NSABP C-07

Journal of clinical oncology, 2007-06, Vol.25 (16), p.2198-2204

2007

Volltextzugriff (PDF)

Prevention of Delayed Nausea: A University of Rochester Cancer Center Community Clinical Oncology Program Study of Patients Receiving Chemotherapy

Journal of clinical oncology, 2012-09, Vol.30 (27), p.3389-3395

2012

Volltextzugriff (PDF)

Prospective Multicenter Study of the Impact of Oncotype DX Colon Cancer Assay Results on Treatment Recommendations in Stage II Colon Cancer Patients

The oncologist (Dayton, Ohio), 2014-05, Vol.19 (5), p.492-497

2014

Volltextzugriff (PDF)

Randomized Phase II Trial of Erlotinib Beyond Progression in Advanced Erlotinib‐Responsive Non‐Small Cell Lung Cancer

The oncologist (Dayton, Ohio), 2015-11, Vol.20 (11), p.1298-1303

2015

Volltextzugriff (PDF)

Neurotoxicity From Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: NSABP C-07

Journal of clinical oncology, 2007-06, Vol.25 (16), p.2205-2211

2007

Volltextzugriff (PDF)

Consolidation Docetaxel After Concurrent Chemoradiotherapy in Stage IIIB Non–Small-Cell Lung Cancer: Phase II Southwest Oncology Group Study S9504

Journal of clinical oncology, 2003-05, Vol.21 (10), p.2004-2010

2003

Volltextzugriff (PDF)

Radioembolization of liver metastases in patients with colorectal cancer: a nonsurgical treatment with combined modality potential

Journal of clinical oncology, 2009-09, Vol.27 (25), p.4041-4042

Kuebler, J Philip

2009

Volltextzugriff (PDF)

Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer

JAMA oncology, 2017-04, Vol.3 (4), p.464

2017

Volltextzugriff (PDF)

Severe enteropathy among patients with stage II/III colon cancer treated on a randomized trial of bolus 5-fluorouracil/leucovorin plus or minus oxaliplatin : A prospective analysis

Cancer, 2007-11, Vol.110 (9), p.1945-1950

2007

Volltextzugriff (PDF)

Effects of a Home‐based Exercise Program on Anxiety and Mood Disturbances in Older Adults with Cancer Receiving Chemotherapy

Journal of the American Geriatrics Society (JAGS), 2019-05, Vol.67 (5), p.1005-1011

2019

Volltextzugriff (PDF)

Patient expectation is a strong predictor of severe nausea after chemotherapy: A University of Rochester Community Clinical Oncology Program study of patients with breast carcinoma

Cancer, 2004-12, Vol.101 (11), p.2701-2708

2004

Volltextzugriff (PDF)

Evaluation of the Combination of Docetaxel/Carboplatin in Patients with Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN): A Southwest Oncology Group Phase II Study

Cancer investigation, 2007-01, Vol.25 (3), p.182-188

2007

Volltextzugriff (PDF)

Recent experience with oxaliplatin or irinotecan combined with 5-fluorouracil and leucovorin in the treatment of colorectal cancer

Seminars in oncology, 2003-08, Vol.30 (4 Suppl 15), p.40-46

2003

Volltextzugriff (PDF)

Patient expectation is a strong predictor of severe nausea after chemotherapy

Cancer, 2004-12, Vol.101 (11), p.2701-2708

2004

Volltextzugriff (PDF)

Pemetrexed/Oxaliplatin for First-Line Treatment of Patients with Advanced Colorectal Cancer: A Phase II Trial of the National Surgical Adjuvant Breast and Bowel Project Foundation Research Program

Clinical colorectal cancer, 2005-09, Vol.5 (3), p.181-187

2005

Volltextzugriff (PDF)

Abstract A201: Mutation profiling and prognostic value of BRAF, HRAS, KRAS, MET, NRAS, PIK3CA, KRASG12V in colon cancer: Results from NSABP C-07

Molecular cancer therapeutics, 2009-12, Vol.8 (12_Supplement), p.A201-A201

2009

Volltextzugriff (PDF)

Severe enteropathy among patients with stage II/III colon cancer treated on a randomized trial of bolus 5‐fluorouracil/leucovorin plus or minus oxaliplatin

Cancer, 2007-11, Vol.110 (9), p.1945-1950

2007

Volltextzugriff (PDF)

Recent experience with oxaliplatin or irinotecan combined with 5-fluorouracil and leucovorin in the treatment of colorectal cancer: Perspectives on oxaliplatin in the treatment of gastrointestinal cancers

Seminars in oncology, 2003, Vol.30 (4), p.40-46

2003

Volltextzugriff (PDF)

Concurrent chemotherapy/radiotherapy for limited small-cell lung carcinoma: a Southwest Oncology Group Study

Journal of clinical oncology, 1990-05, Vol.8 (5), p.892-898

1990

Volltextzugriff (PDF)

A Phase II Study of 9-Aminocamptothecin in Patients with Refractory Breast Cancer

Cancer investigation, 2000, Vol.18 (1), p.28-31

2000

Volltextzugriff (PDF)

Prognostic factors in multiple myeloma

Cancer, 1991-06, Vol.67 (12), p.3150-3156

1991

Volltextzugriff (PDF)

Treatment of Metastatic Renal Cell Carcinoma with Recombinant Interleukin-2 in Combination with Vinblastine or Lymphokine-Activated Killer Cells

The Journal of urology, 1993-09, Vol.150 (3), p.814-820

1993

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Aktive Filter

ThemaPharmacology & Pharmacy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(42)

Sprache

Englisch
(42)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Humans
(32)
Science & Technology
(32)
Life Sciences & Biomedicine
(31)
Oncology
(25)
Middle Aged
(24)
Female
(23)
Male
(22)
Aged
(18)
Adult
(16)
Biological And Medical Sciences
(15)
Medical Sciences
(15)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(14)
Chemotherapy
(13)
Aged, 80 And Over
(12)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(11)
Tumors
(8)
Neoplasm Staging
(7)
Pharmacology. Drug Treatments
(7)
Treatment Outcome
(7)
Antineoplastic Agents
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(10)
Cancer
(8)
Cancer Investigation
(2)
Jama Oncology
(2)
Journal Of The National Medical Association
(2)
Seminars In Oncology
(2)
The Oncologist
(2)
Annals Of Oncology
(1)
Archives Of Neurology
(1)
Biochemistry
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses

Phase III Trial of Irinotecan/Cisplatin Compared With Etoposide/Cisplatin in Extensive-Stage Small-Cell Lung Cancer: Clinical and Pharmacogenomic Results From SWOG S0124

Effects of exercise on inflammation in patients receiving chemotherapy: a nationwide NCORP randomized clinical trial

Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: Results From NSABP C-07

Prevention of Delayed Nausea: A University of Rochester Cancer Center Community Clinical Oncology Program Study of Patients Receiving Chemotherapy

Prospective Multicenter Study of the Impact of Oncotype DX Colon Cancer Assay Results on Treatment Recommendations in Stage II Colon Cancer Patients

Randomized Phase II Trial of Erlotinib Beyond Progression in Advanced Erlotinib‐Responsive Non‐Small Cell Lung Cancer

Neurotoxicity From Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: NSABP C-07

Consolidation Docetaxel After Concurrent Chemoradiotherapy in Stage IIIB Non–Small-Cell Lung Cancer: Phase II Southwest Oncology Group Study S9504

Radioembolization of liver metastases in patients with colorectal cancer: a nonsurgical treatment with combined modality potential

Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer

Severe enteropathy among patients with stage II/III colon cancer treated on a randomized trial of bolus 5-fluorouracil/leucovorin plus or minus oxaliplatin : A prospective analysis

Effects of a Home‐based Exercise Program on Anxiety and Mood Disturbances in Older Adults with Cancer Receiving Chemotherapy

Patient expectation is a strong predictor of severe nausea after chemotherapy: A University of Rochester Community Clinical Oncology Program study of patients with breast carcinoma

Evaluation of the Combination of Docetaxel/Carboplatin in Patients with Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN): A Southwest Oncology Group Phase II Study

Recent experience with oxaliplatin or irinotecan combined with 5-fluorouracil and leucovorin in the treatment of colorectal cancer

Patient expectation is a strong predictor of severe nausea after chemotherapy

Pemetrexed/Oxaliplatin for First-Line Treatment of Patients with Advanced Colorectal Cancer: A Phase II Trial of the National Surgical Adjuvant Breast and Bowel Project Foundation Research Program

Abstract A201: Mutation profiling and prognostic value of BRAF, HRAS, KRAS, MET, NRAS, PIK3CA, KRASG12V in colon cancer: Results from NSABP C-07

Severe enteropathy among patients with stage II/III colon cancer treated on a randomized trial of bolus 5‐fluorouracil/leucovorin plus or minus oxaliplatin

Recent experience with oxaliplatin or irinotecan combined with 5-fluorouracil and leucovorin in the treatment of colorectal cancer: Perspectives on oxaliplatin in the treatment of gastrointestinal cancers

Concurrent chemotherapy/radiotherapy for limited small-cell lung carcinoma: a Southwest Oncology Group Study

A Phase II Study of 9-Aminocamptothecin in Patients with Refractory Breast Cancer

Prognostic factors in multiple myeloma

Treatment of Metastatic Renal Cell Carcinoma with Recombinant Interleukin-2 in Combination with Vinblastine or Lymphokine-Activated Killer Cells

Aktive Filter

Suchergebnisse filtern